期刊文献+

原发性胆汁淤积症11例临床分析 被引量:1

下载PDF
导出
摘要 目的 探究原发性胆汁性肝硬化 (PBC)的临床表现、实验室检查特征及诊断思路。方法 回顾性总结11例PBC患者的详细临床表现、实验室检查的结果。结果 男∶女为 1∶10。持续肝功能异常 ,以结合胆红素、AKP、γ—GT异常升高 ,血嗜酸粒细胞升高 ,AMA阳性及多种合并症存在。结论 对于不明原因之肝功能损害 ,尤其是中年女性 ,表现为阻塞性黄疸、多种肝酶升高、特别是AKP大于正常值 2倍以上 ,γ—GT大于正常值 5~ 10倍 ,并存在免疫性疾病者 ,应高度警惕本病。
出处 《安徽医学》 2003年第1期51-52,共2页 Anhui Medical Journal
  • 相关文献

参考文献4

二级参考文献4

  • 1Lindgren S,Manthorpe R,Eriksson S.Autoimmune liver disease in patients with primary Sj gren′s syndrome[].Journal of Hepatology.1994
  • 2Skopouli FN,Barbatis C,Moutsopoulos HM.Liver involvement in primary Sj gren′s syndrome[].British Journal of Rheumatology.1994
  • 3Zukowski TH,Jorgensen RA,Dickson ER,et al.Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy[].The American journal of Gastroenterology.1998
  • 4Tsuneyama K,Vande Water J,Yamazaki K,et al.Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry[].Autoimmunity.1997

共引文献3

同被引文献13

  • 1Feld JJ,Heathcote EJ.Epidemiology of autoimmune liver disease.J Gastroenterol Hepatol,2003,18:1118-1128.
  • 2Muratori L,Granito A,Muratori P,et al.Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis:diagnostic and prognostic value.Clin Liver Dis,2008,12:261-276.
  • 3Bogdanos DP,Liaskos C,Pares A,et al.Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.Hepatology,2007,45:1583.
  • 4Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines.Hepatology,2000,31:1005-1013.
  • 5Dickson ER,Grambsch PM,Fleming TR,et al.Prognosis in primary biliary cirrhosis:model for decision making.Hepatology,1990,11:518-520.
  • 6Nakamura M,Kondo H,Mori T,et al.Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.Hepatology,2007,45:118-127.
  • 7Itoh S,Ichida T,Yoshida T,et al.Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.J Gastroenterol Hepatol,1998,13:257-265.
  • 8Nakamura M,Shimizu-Yoshida Y,Takii Y,et al.Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.J Hepatol,2005,42:386-392.
  • 9Bogdanos DP,Baum H,Butler P,et al.Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.Dig Liver Dis,2003,35:801-805.
  • 10Corpechot C,Abenavoli L,Rabahi N,et al.Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.Hepatology,2009,49:337-338.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部